Although our data suggest a tumour-suppressor-like role for CD99 in cancer progression, other cancers, such as Ewing's sarcoma and glioma, demonstrate oncogene-like activity of CD99 (Manara et al., 2018; Rocchi et al., 2010; Seol et al., 2012). Here, CD99 is linked to central nervous system cancer.